Cargando…

The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis

BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xin, Zheng, Yanhua, Xu, Li, Cao, Chun, Dong, Baoxia, Chen, Xiequn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708708/
https://www.ncbi.nlm.nih.gov/pubmed/31145332
http://dx.doi.org/10.1097/MD.0000000000015844
_version_ 1783446052131569664
author Shi, Xin
Zheng, Yanhua
Xu, Li
Cao, Chun
Dong, Baoxia
Chen, Xiequn
author_facet Shi, Xin
Zheng, Yanhua
Xu, Li
Cao, Chun
Dong, Baoxia
Chen, Xiequn
author_sort Shi, Xin
collection PubMed
description BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, have yielded controversial results. Thus, we performed a meta-analysis to assess the levels of these inflammatory cytokines in MDS. METHODS: A systematic search in PubMed, MEDLINE, Cochrane Library, Web of Science, CNKI, and CBM was conducted to find eligible studies. Meta-analyses were performed using STATA 12.0 for Windows. Heterogeneity between included studies was assessed by I(2) test. We chose SMD as the summary statistic. RESULTS: A total of 697 individuals from 11 studies were included in this study. Our results suggest the levels of TNF-α, IL-6, IL-8 were significantly higher in MDS patients compared with controls, SMD and 95%CI was 1.48 (0.60, 2.36), 0.71 (0.16, 1.25) and 0.69 (0.28, 1.09), respectively. Moreover, the levels of IL-17 have decreased in the high-risk MDS, the SMD and 95% CI was 2.96 (0.78, 5.15). CONCLUSION: A close association between immunological microenvironment disorders and the pathogenesis of MDS was revealed in this meta-analysis. More importantly, the profiles of inflammatory cytokines appear to change along the progression of the disease.
format Online
Article
Text
id pubmed-6708708
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67087082019-10-01 The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis Shi, Xin Zheng, Yanhua Xu, Li Cao, Chun Dong, Baoxia Chen, Xiequn Medicine (Baltimore) Research Article BACKGROUND: Accumulating evidence has indicated that the dysregulation of immunological environment has an important role in the pathogenesis of myelodysplastic syndromes (MDS). The previous studies about the levels of the inflammatory cytokines in MDS, such as TNF-α, IFN-γ, IL-6, IL-8, and IL-17, have yielded controversial results. Thus, we performed a meta-analysis to assess the levels of these inflammatory cytokines in MDS. METHODS: A systematic search in PubMed, MEDLINE, Cochrane Library, Web of Science, CNKI, and CBM was conducted to find eligible studies. Meta-analyses were performed using STATA 12.0 for Windows. Heterogeneity between included studies was assessed by I(2) test. We chose SMD as the summary statistic. RESULTS: A total of 697 individuals from 11 studies were included in this study. Our results suggest the levels of TNF-α, IL-6, IL-8 were significantly higher in MDS patients compared with controls, SMD and 95%CI was 1.48 (0.60, 2.36), 0.71 (0.16, 1.25) and 0.69 (0.28, 1.09), respectively. Moreover, the levels of IL-17 have decreased in the high-risk MDS, the SMD and 95% CI was 2.96 (0.78, 5.15). CONCLUSION: A close association between immunological microenvironment disorders and the pathogenesis of MDS was revealed in this meta-analysis. More importantly, the profiles of inflammatory cytokines appear to change along the progression of the disease. Wolters Kluwer Health 2019-05-31 /pmc/articles/PMC6708708/ /pubmed/31145332 http://dx.doi.org/10.1097/MD.0000000000015844 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Research Article
Shi, Xin
Zheng, Yanhua
Xu, Li
Cao, Chun
Dong, Baoxia
Chen, Xiequn
The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title_full The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title_fullStr The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title_full_unstemmed The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title_short The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
title_sort inflammatory cytokine profile of myelodysplastic syndromes: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708708/
https://www.ncbi.nlm.nih.gov/pubmed/31145332
http://dx.doi.org/10.1097/MD.0000000000015844
work_keys_str_mv AT shixin theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT zhengyanhua theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT xuli theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT caochun theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT dongbaoxia theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT chenxiequn theinflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT shixin inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT zhengyanhua inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT xuli inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT caochun inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT dongbaoxia inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis
AT chenxiequn inflammatorycytokineprofileofmyelodysplasticsyndromesametaanalysis